Radiohalogenated half-antibodies and maleimide intermediate therefor
Patent
·
OSTI ID:867713
- Chestnut Hill, MA
- Newton Centre, MA
N-(m-radiohalophenyl) maleimide can be conjugated with a reduced antibody having a mercapto group to provide a radiolabelled half-antibody having immunological specific binding characteristics of whole antibody.
- Research Organization:
- Massachusetts Inst. of Technology (MIT), Cambridge, MA (United States)
- DOE Contract Number:
- FG02-86ER60460
- Assignee:
- President and Fellows of Harvard College (Cambridge, MA)
- Patent Number(s):
- US 4994557
- OSTI ID:
- 867713
- Country of Publication:
- United States
- Language:
- English
Similar Records
Radiohalogenated half-antibodies and maleimide intermediate therefor
Employment of a macrocyclic amine bifunctional chelate to label antibodies
Model system that predicts effective half-life for radiolabeled antibody therapy. [Rats]
Patent
·
Tue Feb 19 00:00:00 EST 1991
·
OSTI ID:867713
Employment of a macrocyclic amine bifunctional chelate to label antibodies
Conference
·
Wed May 01 00:00:00 EDT 1985
· J. Nucl. Med.; (United States)
·
OSTI ID:867713
+2 more
Model system that predicts effective half-life for radiolabeled antibody therapy. [Rats]
Journal Article
·
Thu Aug 01 00:00:00 EDT 1985
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
·
OSTI ID:867713
+3 more